Dr. Daniel Lundberg received his B.S. from Gallaudet University in 2002. Immediately after graduation, he was accepted as a post-baccalaureate fellow at the National Cancer Institute (NCI), NIH for one year where he studied and contributed to publications in signal transduction pathways important in cancer and pain. He then received a Ph.D. in Pharmacology from the University of Minnesota-Twin Cities Medical School in 2008. The focus of his dissertation was on cannabinoid modulation of synaptic transmission.
Dr. Lundberg currently is involved in two projects. The first project focuses on the Ras guanyl nucleotide releasing-protein (RasGRP), which plays a role in cancer. In the Gallaudet University Molecular Genetics Laboratory, the DNA is genetically engineered, bioengineered RasGRP is synthesized in bacteria, and its sensitivity to synthesized drugs is tested.
The second project uses Carlson's Trophic State Index to determine the water quality of both the Anacostia River in Washington, DC and Maryland during the academic year and north-central Minnesota lakes during the summer. Plans are currently underway to determine pharmaceutical waste in these freshwater systems.